Reuters Events: Pharma 2024

Let's step into the world of pharmaceuticals, where we constantly experience challenges and opportunities. With a keen focus on patients, payers, policymakers, HTAs, and customers, the pharma industry is exploring new scientific territories and introducing groundbreaking technologies to address these challenges and conquer these opportunities. 

The promise of existing digital tools such as AI or ML is truly exciting, as they significantly enhance medicine. By leveraging real-world data and external sources and integrating AI into research and development, clinical trials or drug discovery, supply chain management and operations, or pharmacovigilance, we're poised to transform healthcare for significantly improved patient outcomes.

But how? 

Beyond technology lies collaboration and embracing innovations. A brighter pharmaceutical future demands stakeholders to work together so that everyone shares their innovations and expertise for combined success.

Over 1200 leading pharma changemakers from commercial, marketing, medical affairs, patient engagement, market access, RWE, and digital health are gathering at Reuters' Pharma 2024 to accomplish this level of collaboration and ensure a digitally empowered future for the life sciences industry. 
 

Nagarro at Reuters Events: Pharma 2024

We look forward to meeting the brightest minds at Pharma 2024, Barcelona and discussing how we enable innovation and efficiency with technology.

Having collaborated with leading pharmaceutical & biotech companies and contract research organizations in developing digital solutions for new drugs and treatments, Nagarro brings a unique skill set and expertise to Pharma 2024. 

Panel discussion: Boost your digital health solutions with reliable partnerships, sustainable data management, and the latest AI-models 

April 17, 2024, 4:50PM (CET) 
 

Andrei Doibani from Nagarro will moderate the discussion on accelerating digital transformations through AI and machine learning technologies.  
  
The panel will explore the importance of user-friendly designs in patient-facing digital health solutions, detangling complex data input streams from growing digital health ecosystems and the significance of partnerships and collaborations in unleashing the full potential of technological innovation.
 
Panel members: 

• Sridevi Nagarajan - Head of Digital Regulatory Strategy, AstraZeneca  
• Spencer Jones - Spencer Jones - Executive Director, Digital Health Oncology, Bristol Myers Squibb
• Grégoire Guillet - Chief Business & Value Officer, WeHealth Digital Factory, Servier  
• Lu Zheng - Head of Value-Based Partnerships and Digital Health, Europe & Canada, Takeda  
• Andrei Doibani -  Head of Global Business Unit, Life Sciences and Healthcare, Nagarro